Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety of intravenous infusion of cultured allogeneic adult umbilical cord–derived mesenchymal stem cells in indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING